ESTIMANDS AND STRATEGIES FOR HANDLING TREATMENT SWITCHING AS AN INTERCURRENT EVENT IN EVIDENCE SYNTHESIS OF RANDOMIZED CLINICAL TRIALS IN ONCOLOGY

被引：0
|
作者：
Metcalfe, R. [1 ]
Gorst-Rasmussen, A. [2 ]
Morga, A. [3 ]
Remiro, Azocar A. [4 ]
Park, J. [1 ]
机构：
[1] Core Clin Sci, Vancouver, BC, Canada
[2] Novo Nordisk AS, Copenhagen, Denmark
[3] Astellas Pharma Europe Ltd, Addlestone, Surrey, England
[4] Bayer PLC, Reading, Berks, England
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
MSR80
引用
收藏
页码：S274 / S275
页数：2
相关论文
共 50 条
  • [1] Estimands for overall survival in clinical trials with treatment switching in oncology
    Manitz, Juliane
    Kan-Dobrosky, Natalia
    Buchner, Hannes
    Casadebaig, Marie-Laure
    Degtyarev, Evgeny
    Dey, Jyotirmoy
    Haddad, Vincent
    Jie, Fei
    Martin, Emily
    Mo, Mindy
    Rufibach, Kaspar
    Shentu, Yue
    Stalbovskaya, Viktoriya
    Tang, Rui
    Yung, Godwin
    Zhou, Jiangxiu
    PHARMACEUTICAL STATISTICS, 2022, 21 (01) : 150 - 162
  • [2] Translating questions to estimands in randomized clinical trials with intercurrent events
    Stensrud, Mats J.
    Dukes, Oliver
    STATISTICS IN MEDICINE, 2022, 41 (16) : 3211 - 3228
  • [3] Defining estimands using a mix of strategies to handle intercurrent events in clinical trials
    Qu, Yongming
    Shurzinske, Linda
    Sethuraman, Shanthi
    PHARMACEUTICAL STATISTICS, 2021, 20 (02) : 314 - 323
  • [4] Handling of Allograft As an Intercurrent Event in Randomized Controlled Trials in Acute Leukemias: A Systematic Review
    Couturier, Roxane
    Vasseur, Loic
    Boissel, Nicolas
    Dombret, Herve
    Chevret, Sylvie
    Lambert, Jerome
    BLOOD, 2024, 144 : 7449 - 7450
  • [5] Handling death as an intercurrent event in time to recovery analysis in COVID-19 treatment clinical trials
    Li, Hong
    Gleason, Kevin J.
    Hu, Yiran
    Lovell, Sandra S.
    Mukhopadhyay, Saurabh
    Wang, Li
    Huang, Bidan
    CONTEMPORARY CLINICAL TRIALS, 2022, 119
  • [6] The net benefit for time-to-event outcome in oncology clinical trials with treatment switching
    Fukuda, Musashi
    Sakamaki, Kentaro
    Oba, Koji
    CLINICAL TRIALS, 2023, 20 (06) : 670 - 680
  • [7] Conditional and Unconditional Treatment Effects in Randomized Clinical Trials: Estimands, Estimation, and Interpretation
    Wei, Jiawei
    Xu, Jiajun
    Bornkamp, Bjorn
    Lin, Ray
    Tian, Hong
    Xi, Dong
    Zhang, Xin
    Zhao, Ziqiang
    Roychoudhury, Satrajit
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2024, 16 (03): : 371 - 381
  • [8] Estimating and reporting treatment effects in clinical trials for weight management: using estimands to interpret effects of intercurrent events and missing data
    Sean Wharton
    Arne Astrup
    Lars Endahl
    Michael E. J. Lean
    Altynai Satylganova
    Dorthe Skovgaard
    Thomas A. Wadden
    John P. H. Wilding
    International Journal of Obesity, 2021, 45 : 923 - 933
  • [9] Estimating and reporting treatment effects in clinical trials for weight management: using estimands to interpret effects of intercurrent events and missing data
    Wharton, Sean
    Astrup, Arne
    Endahl, Lars
    Lean, Michael E. J.
    Satylganova, Altynai
    Skovgaard, Dorthe
    Wadden, Thomas A.
    Wilding, John P. H.
    INTERNATIONAL JOURNAL OF OBESITY, 2021, 45 (05) : 923 - 933
  • [10] Estimands for clinical endpoints in tuberculosis treatment randomized controlled trials: a retrospective application in a completed trial
    Isabelle R. Weir
    Suzanne M. Dufault
    Patrick P. J. Phillips
    Trials, 25
12345